Influence of metabolic syndrome on hypertension-related target organ damage.
OBJECTIVE
The aim of our study was to analyse, in a wide group of essential hypertensive patients without diabetes mellitus, the influence of metabolic syndrome (MS) (defined according to the criteria laid down in the Third Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults) on markers of preclinical cardiac, renal and retinal damage.


METHODS
Cross-sectional study.


METHODS
Outpatient hypertension clinic.


METHODS
A total of 353 young and middle-aged hypertensives, free from cardiovascular and renal diseases (and 37% of whom had MS), underwent echocardiographic examination, microalbuminuria determination and non-mydriatic retinography.


RESULTS
When compared with subjects without MS, hypertensive patients with MS exhibited more elevated left ventricular (LV) mass (either normalized by body surface area or by height elevated by a power of 2.7), higher myocardial relative wall thickness, albumin excretion rate (AER) and a greater prevalence of LV hypertrophy (57.7% vs. 25.1%; P < 0.00001), of microalbuminuria (36.2% vs. 19.3%; P = 0.002) and of hypertensive retinopathy (87.7% vs. 48.4%; P < 0.00001). These results held even after correction for age, 24-h blood pressures, duration of hypertension, previous antihypertensive therapy, and gender distribution. The independent relationships between LV mass and MS, and between AER and MS, were confirmed in multivariate regression models including MS together with its individual components.


CONCLUSIONS
MS may amplify hypertension-related cardiac and renal changes, over and above the potential contribution of each single component of this syndrome. As these markers of target organ damage are well-known predictors of cardiovascular events, our results may partly explain the enhanced cardiovascular risk associated with MS.
Mulè
G
G
Dipartimento di Medicina Interna, Malattie Cardiovascolari e Nefrourologiche, Università di Palermo, Palermo, Italy. giusemme@email.it
Nardi
E
E
Cottone
S
S
Cusimano
P
P
Volpe
V
V
Piazza
G
G
Mongiovì
R
R
Mezzatesta
G
G
Andronico
G
G
Cerasola
G
G
D000328:Adult; D000419:Albuminuria / Q000209:etiology; D000959:Antihypertensive Agents / Q000627:therapeutic use; D003430:Cross-Sectional Studies; D005260:Female; D006352:Heart Ventricles / Q000473:pathology; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy / Q000473:pathology*; D017379:Hypertrophy, Left Ventricular / Q000209:etiology; D007668:Kidney / Q000473:pathology; D008297:Male; D024821:Metabolic Syndrome / Q000150:complications / Q000473:pathology*; D008875:Middle Aged; D009206:Myocardium / Q000473:pathology; D009765:Obesity / Q000150:complications; D012044:Regression Analysis; D012160:Retina / Q000473:pathology; D012164:Retinal Diseases / Q000209:etiology; D017678:Sex Distribution
D000959:Antihypertensive Agents